Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_ebook_updated-0723-FINAL-1
Brexit is here - Is your clinical trial-ready?

The United Kingdom officially withdrew from the European Union (EU) on Jan 31, 2020. They have until Dec 31, 2020 to complete...


(3 minute read)

Tags: Pharm-Olam Insights, Global Coverage

The Benefits of Conducting Clinical Research in Russia

Pharm-Olam, as a global CRO, has over 20 years' experience conducting clinical trials in Central and Eastern Europe (CEE). In...


(4 minute read)

Tags: Pharm-Olam Insights, Global Coverage

Current Trends in Allergy Immunotherapy

Pharm-Olam is an allergy focused CRO and have worked on over 35 allergy clinical trials. In this article, we explore the area...


(8 minute read)

Tags: Pharm-Olam Insights, Allergy & Immunology

Medical Data Reviewer: Pharm-Olam’s Secret to Study Success

Effective Data management plays a critical role in the conduct of clinical trials. Clinical research requires quality data...


(1 minute read)

Tags: Pharm-Olam Insights, Data Management

Challenges Working with Terminally-Ill Patients in an International Rare Disease Study

Pharm-Olam is a clinical research organization (CRO) that has vast experience in rare diseases. To date, we have completed...


(3 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Natural History - Case Study: Ultra Rare Disease in Subjects Aged 3 Years and Younger

Pharm-Olam is a clinical research organization (CRO) with global reach and deep expertise in rare disease research. Our...


(3 minute read)

Tags: Rare & Orphan Disease

Complexities of Combining Adults into Protocol with Pediatrics and Adolescents

Conducting Phase I studies is always complex. At this stage in clinical research, you are examining the tolerability of the...


(1 minute read)

Tags: Pharm-Olam Insights, Allergy & Immunology

How Rave CSA Supports Remote Monitoring in COVID-19

In a world with COVID-19, remote monitoring is now essential to effectively monitor studies. Sponsors and CROs are either...


(2 minute read)

Tags: Pharm-Olam Insights, COVID-19

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover